The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of CA125/MUC16 on complement-dependent cytotoxicity (CDC) of farletuzumab and other CDC-mediating antibodies via inhibition of antibody-C1q binding.
 
J Bradford Kline
Employment - Morphotek
Research Funding - Morphotek (Inst)
Patents, Royalties, Other Intellectual Property - Morphotek
Travel, Accommodations, Expenses - Morphotek
 
Shawn Fernando
Employment - Morphotek
Research Funding - Morphotek
Travel, Accommodations, Expenses - Morphotek
 
Stephen Harley
Employment - Morphotek
Research Funding - Morphotek
Travel, Accommodations, Expenses - Morphotek
 
Luigi Grasso
Employment - Morphotek
Leadership - Morphotek
Research Funding - Morphotek
Patents, Royalties, Other Intellectual Property - Morphotek
Travel, Accommodations, Expenses - Morphotek
 
Nicholas C Nicolaides
Employment - Morphotek
Leadership - Egalet Corporation; Morphotek
Stock and Other Ownership Interests - Egalet Corporation; Exelixis
Research Funding - Morphotek
Patents, Royalties, Other Intellectual Property - Morphotek
Travel, Accommodations, Expenses - Morphotek